Industri

Made Scientific acquires cell therapy facility in Penns...

The company said programmes could be onboarded at the facility immediately, rath...

GCF organises three day conference on ‘Advancing green ...

The pharmaceutical industry is increasingly focusing on integrating Green and S...

BDR Pharmaceuticals International appoints Niral Bhatt ...

BDR Pharmaceuticals International Pvt Ltd has announced the appointment of Nira...

India’s biotech self-reliance moment 

For much of the past two decades, global biotech leadership has clustered aroun...

Lex Witness announces 12th Annual Pharmaceutical Legal ...

Like previous editions, the Summit will focus on practical perspectives, peer l...

Andelyn Biosciences begins commercial manufacturing of ...

Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contra...

The Hidden Cost of Value Engineering MEP

Value engineering MEP systems rarely involves a single major decision. The post ...

Telix to acquire ITM in deal worth up to $2.35bn

The Australian company will pay $1.65bn upfront on a cash-free, debt-free basis....

Sandoz and mAbxience agree on emicizumab biosimilar par...

The candidate is in early-stage development and references Hemlibra (emicizumab)...

How pharma is charting a greener path to growth 

The conversation around environmental sustainability in the pharma industry is ...

Akums announces DCGI-approved triple therapy for H. pyl...

Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved ...

Biocon receives EMA CHMP approval for Pertuzumab biosim...

Biocon Biologics announced that the Committee for Medicinal Products for Human ...

Why pharma needs smarter decision-making, not just more...

The pharmaceutical industry has invested heavily in digitisation over the past f...

Healthcare Beyond Walls: Designing the Future of Care

Leon Medical Centers in Homestead, Fla., repurposed a former multiplex theater i...

Ona Therapeutics to develop ADC with WuXi’s payload-lin...

The deal grants Ona Therapeutics rights to develop the ADC targeting a single un...

Roche agrees $1bn deal with Dualitas for bispecific ant...

Under this arrangement, Dualitas will use its DualScreen Bispecific Discovery En...